LFCR
Lifecore Biomedical, Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
Lifecore Biomedical (LFCR) Stock: Buy, Sell, or Hold?
$6.40
+0.03 (+0.47%)
▲
5d:
-0.62%
30d:
-0.31%
90d:
+35.31%
QUANTITATIVE VERDICT
HOLD
MODERATE Confidence (76%)
Quality Score
56/100
Position
FAIR
30-Day Fair Range
$6.38 – $6.46
Position: FAIR
Forward P/E & Valuation
-11.7x
Next 12M consensus est.
Wall Street Target
$6.28
-1.9% vs target
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$6.32 / $6.52
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: LFCR shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
Get Alerted When LFCR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: LFCR is currently trading at $6.40, which is considered fair relative to its 30-day fair value range of $6.38 to $6.46.
Technical Outlook: Technically, LFCR is in a strong uptrend. The price is currently testing key support at $6.32. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 46/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, LFCR is in a strong uptrend. The price is currently testing key support at $6.32. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 46/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$6.38 -
$6.46
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
75.8%
Trading Range & Key Levels
30-Day Trading Range
$6.38 -
$6.46
Current vs Trading Range
FAIR
Expected Move (7 Days)
±$0.68
(10.7%)
Support Level
$6.32
Resistance Level
$6.52
Current Trend
Strong Uptrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- BULLISH: Options cheap (IV 0th percentile)
- NEUTRAL: Mixed technical signals (46/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($6.28)
- NEUTRAL: Bottoming setup forming (46/100) — watch for confirmation
Fundamental Context
Forward P/E (Next Year Est.)
-11.74
Wall Street Target
$6.28
(-1.9%)
Revenue Growth (YoY)
-18.6%
Profit Margin
-66.8%
Share LFCR Analysis
Share this live LFCR analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (LFCR)
Bullish
4 Retail Mentions
StockTwits Volume
4 msgs
24h retail stream
Last Tracked
Sep 28, 2026
Daily AI digest
AI Retail Discussion Summary:
Lifecore Biomedical (LFCR) announced its acquisition by Webster Equity Partners for $6.28 per share, representing a 49.5% premium. The deal, valued at up to $663.7 million, includes contingent value rights (CVRs) for up to $160 million in aggregate cash payments.
Key Retail Themes:
M&A activity
Growth prospects
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 6:56 AM ET
Data refreshes hourly during market hours. Next update: 7:56 AM
Data refreshes hourly during market hours. Next update: 7:56 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LFCR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
29 analysts |
$208 | 23 SELL |
|
ALKS
Alkermes Plc |
STRONG BUY
20 analysts |
$58 | 33 SELL |
|
AQST
Aquestive Therapeutics I… |
STRONG BUY
9 analysts |
$9 | 62 BUY |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$687 | 52 HOLD |
|
HROW
Harrow Health Inc |
STRONG BUY
9 analysts |
$63 | 53 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive LFCR Research Pages
